|
 |
|
| March 7~9, 2007
Raffles City Convention Center, Singapore |
 |
|
| Keynote
Lectures |
|
|
Time |
Keynote
Lectures |
Speakers |
Keynote
Lectures
1
March 7, 2007
11:00
am - 12:30
pm |
History of
antimicrobial therapy for the past
60 years - lessons for the future |
Walter R.
Wilson
(Mayo Clinic, USA) |
|
|
| Discovery of novel antimicrobial
agents |
Robert Moellering
(Beth larael Deaconess Medical Center, USA) |
|
Keynote
Lecture
2
March 8, 2007
4:30 pm -
5:15 pm |
Antimicrobial
stewardship |
Wing Hong
Seto
(Queen Mary Hospital, Hong
Kong) |
|
Keynote
Lectures
3
March 8, 2007
11:00 am - 12:30 pm |
Roles
of a national
antibiotic
reference
laboratory |
David Livermore
(Health Protection Agency Centre
for Infections, UK) |
|
|
| International network
for surveillance and strategies |
Jae-Hoon Song
(Samsung Medical center, Korea)
|
|
Keynote
Lecture
4
March 8, 2007
4:30 pm -
5:15 pm |
Update on HIV/AIDS Pandemic |
Zelalem Temesgen
(Mayo Clinic, USA)
|
|
Keynote
Lecture
5
March 9, 2007
11:00 am -
12:30 pm |
Clinical study design
in evaluating antibacterial agents |
Michael Jacobs (Case Western
Reserve Univ. USA) |
|
|
| March
7, 200709:00 ~ 10:30 |
|
|
S1 |
Community-acquired
pneumonia |
Speakers |
|
S
1.1 |
Pneumococcal
resistance
&
clinical
implications |
Jae-Hoon
Song
(Samsung
Medical
center,
Korea) |
|
|
S
1.2 |
Mechanisms
of pneumococcal
resistance
and their
clinical
implications |
Donald
Low
(Mount
Sinai
Hospital,
Canada)
|
|
|
S
1.3 |
Treating
CAP in
the era
of resistance |
Keith
Klugman
(Emory
Univ.,
USA)
|
|
|
S2 |
VRE |
Speakers |
| S
2.1 |
Resistance
mechanisms of VRE |
Robin Patel
(Mayo Clinic, USA) |
|
| S
2.2 |
Therapy of
VRE Infections |
Robert Moellering
(Beth Israel Deaconess Medical Center, USA)
|
|
| S
2.3 |
Controlling
VRE |
Brenda Ang
(Tan Tock Seng Hospital, Singapore)
|
|
|
S3 |
Staphylococcal
Resistance |
Speakers |
|
S
3.1 |
CA-MRSA |
Li Yang Hsu
(National University Hospital, Singapore)
|
|
|
S
3.2 |
VISA/hVISA
and VRSA,
mechanism
and clinical
significance |
Keiichi
Hiramatsu
(Juntendo
Univ.,
Japan)
|
|
|
S
3.3 |
Treating
staphylococcal
infections
in the
era of
resistance |
Visanu
Thamlikitkul
(Siriraj
Hospital,
Thailand)
|
|
|
| March
7, 200714:30 ~ 16:00 |
|
|
S4 |
The Bug and the Lab |
Speakers |
| S
4.1 |
Updates and
controversial issues in susceptibility testing
from the CLSI perspective |
Mary Jane
Ferraro
(Massachusetts General Hospital, USA) |
|
| S
4.2 |
Detecting
of resistant bacteria fast - What’s new? |
Frank Cockerill
(Mayo Clinic, USA) |
|
| S
4.3 |
Microbial
typing - A weapon against resistance? |
Robin Patel
(Mayo Clinic, USA)
|
|
|
S5 |
HIV/AIDS |
Speakers |
| S 5.1 |
HIV/AIDS in
India and SE Asia |
Dilip Mathai
(Christian Medical College & Hospital,
India) |
|
| S 5.2 |
Treating HIV/AIDS
in the era of resistance |
Adeeba Kamarulzaman
(Univ. of Malaya, Malaysia) |
|
| S 5.3 |
Approach to
the treatment of heavily antiretroviral therapy
- experienced HIV-infected patients |
Zelalem Temesgen
(Mayo Clinic, USA) |
|
| S6 |
Interactive
session: community infections
|
| Chair
: Brenda Ang (Tan Tock Seng Hospital, Singapore)
Panels:
Walter Wilson (Mayo Clinic, USA)
Donald Low (Mount Sinai Hospital, Canada)
Dale Fisher (National Hospital, Singapore) |
|
|
| March
8, 200709:00 ~ 10:30 |
|
| March
8, 200714:30 ~ 16:00 |
|
|
S10 |
PK/PD : The way to go? |
Speakers |
| S
10.1 |
Applying PK/PD
- Will it help against resistance? |
John Turnidge
(Women's and Children's Hospital, Australia)
|
|
| S
10.2 |
Are all quinolones
equal with regard to resistance? |
David Hooper
(Massachusetts General Hospital, USA) |
|
| S
10.3 |
Vancomycin
Dosing - Can we do Better? |
Robert Moellering
(Beth Israel Deaconess Medical Center, USA) |
|
|
S11 |
Pediatric
infections |
Speakers |
| S 11.1 |
Impact of
resistance on clinical practice in pediatrics
|
Nancy Henry
(Mayo Clinic, USA)
|
|
| S 11.2 |
The ear, nose
and throat: Resistance hideouts |
Ron Dagan
(Soroka University Medical Center, Israel)
|
|
| S 11.3 |
Pneumococcal
vaccination |
Keith Klugman
(Emory Univ., USA)
|
|
| S12 |
Interactive
session: Nosocomial infections
|
| Chair
: Ban Hock Tan (Singapore General Hospital,
Singapore)
Panels:
Walter Wilson (Mayo Clinic, USA)
David Denning (Wythenshawe Hospital, UK)
Po-Ren Hsueh (National Taiwan University
Hospital, Taiwan) |
|
|
| March
9, 200709:00 ~ 10:30 |
|
| March
9, 200714:30 ~ 16:00 |
|
|
|
| ** Not confirmed. |
|
|
|
